MEDISOMedical Venture/Total Support Service sponsored by the Ministry of Health,
Labour and Welfare Comprehensive portal siteMedical Innovation Support Office

厚生労働省

Knowledgeable experts support the commercialization of medicines, medical devices, and regenerative medicinal products.

What is MEDISO ?

MEDISO, an acronym for Medical Innovation Support Office,
is a comprehensive portal site offering total support for medical commercial ventures.
MEDISO supports ventures, academia, and individuals aiming to commercialize medicines,
medical devices, and regenerative medicinal products.
About Medical Venture/Total Support Service

About Medical Venture/Total Support Service

The medical venture and total support service matches the human resources (supporter) who provide advice to medical venture companies with the need for detailed consultation and comprehensive support according to each stage from research and development to practical use and insurance receipt (official price setting) at clinical sites, while looking ahead to overall advances and dissemination into the global market.

Support targets

Ventures, academia, and individuals aiming to commercialize medicines, medical devices, and regenerative medicinal products subject to the Pharmaceuticals and Medical Devices Law.

Details of support

We provide support for the commercialization of medicines, medical devices, regenerative medicinal products, and other products subject to the Pharmaceuticals and Medical Devices Law. Support includes business planning, financing, response to laws and regulations, and other assistance as required.

Click here for queries and consultation requests

Consultation flow

STEP1Consultation acceptance

  • Application from MEDISO and creation of consultation acceptance forms

STEP2Prior interviews

  • Prior exchange of opinions on the consultation
  • Fitting of support plans
  • Selection of experts (supporters)

STEP3Supporter interviews

  • Interviews between consulters and supporters
  • Discussion of the consultation details
  • Consideration and instruction in future support measures

STEP4Follow up

  • Confirmation that there are no remaining questions about the interview
  • Confirmation status after the interview

About supporters

Supporters are experts in each field of research and development, pharmaceutical affairs and insurance, intellectual property management, management and financial accounting, marketing, legal affairs, and international development.
Depending on the specifics of your request, we provide support in cooperation with appropriate experts and related organizations, including the Ministry of Health, Labour and Welfare.

Masaya Nakano

Representative director, Global Business Development Institute, Inc.

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Marketing
  • business planning
  • business operation systems

He graduated with a master's degree in applied chemistry from the Graduate School of Science and Engineering, Waseda University. He provided survey and consulting services, such as marketing surveys, business planning, overseas business development support, as an employee of Mitsubishi Research Institute, Inc. In 2012, he became independent and established the Global Business Development Institute, Inc., as the president. As a small and medium enterprise (SME) management consultant, he provided survey and consulting services in support of SMEs and venture companies.
Work experience:
・Survey and analysis services related to overseas medical needs and the status of overseas business development by domestic companies
・Formulation of management corrective action programs for small and medium enterprises and monitoring of the implementation
・Support for overseas business development by venture companies
・Miscellaneous achievements in marketing surveys and business planning

Lliling Chen

Representative, C-suite Limited liability company

Main specialty areas

  • medicines
  • medical devices

Specialized support fields

  • Marketing
  • business planning
  • business operation system

She graduated with a master's degree from the Graduate School of Medicine, Keio University. She is a licensed pharmacist and a certified pharmacist in Chinese herbal medicines and crude drugs. At Mitsubishi Research Institute, Inc., she worked on medical device projects and led clinical needs assessments and product evaluations. As a consultant, she has extensive experience in marketing support for medical devices and pharmaceutical companies. In particular, her strengths are providing advise from the perspective of medical users based on her experience in hospital consultancy. Taking advantage of her knowledge of pharmacology, she provides support for local economic development projects using medicinal crops. In 2017, she established the C-suite limited liability company.
Main article: How should the hospital/medical industry consider medical technology assessment? – Evaluation of medical economic effects of measures against infectious diseases using AEP – (Mitsubishi Research Institute Report No. 56, 2013), etc.

Yukari Kume

Freelance

Main specialty areas

  • Other

Specialized support fields

  • Communication with overseas experts (response to laws and regulations and marketing)

She graduated with a master's degree from the Graduate School of Philosophy, Sophia University. After studying in the US for three years, she returned to Japan to work as an interpreter and translator of English at a semiconductor manufacturer and an IT company for more than 10 years. In 2012, she joined Mitsubishi Research Institute, Inc., to translate technology into English and was involved in surveys of overseas laws and regulations and the technical regulations governing suitability assessment and authorizations in the fields of railways, aircrafts, and consumer products. From November 2015, she has provided surveys as a freelance consultant.

See supporters (Japanese pages)

Introduction of measures by public institutions

We will introduce support measures from public institutions for pharmaceutical companies, medical device companies,
companies manufacturing regenerative medicinal products, and venture companies.

See the measures implemented by public institutionss (Japanese pages)